Evaluation: Imaging Studies.

The malignant or benign nature of a salivary gland (SG) tumor can be predicted with reasonably high accuracy by imaging. There is some overlap between the imaging findings of benign and malignant tumors, particularly for low-grade malignancies, and tissue diagnosis remains necessary for definitive diagnosis. Magnetic resonance imaging is the modality of choice for the evaluation of salivary neoplasms, as it allows for delineation of local infiltration, perineural spread and intracranial extension. This review will focus on the advanced imaging techniques that help to characterize SG tumors. A brief overview of the conventional imaging features of SG neoplasms is necessary before a discussion of the advanced imaging methods.

[1]  L. Giovanella,et al.  Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis , 2015, European Archives of Oto-Rhino-Laryngology.

[2]  T. Kurabayashi,et al.  Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution. , 2015, The British journal of radiology.

[3]  D. Knol,et al.  Diffusion-Weighted Imaging of the Head and Neck in Healthy Subjects: Reproducibility of ADC Values in Different MRI Systems and Repeat Sessions , 2015, American Journal of Neuroradiology.

[4]  S. Mugikura,et al.  Diagnostic value of capsule-like rim enhancement on magnetic resonance imaging for distinguishing malignant from benign parotid tumours. , 2014, International journal of oral and maxillofacial surgery.

[5]  M. Kanematsu,et al.  Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components , 2014, Neuroradiology.

[6]  A. Chhabra,et al.  Anatomic considerations, nomenclature, and advanced cross-sectional imaging techniques for visualization of the cranial nerve segments by MR imaging. , 2014, Neuroimaging clinics of North America.

[7]  Y.J. Kim,et al.  Differentiation of Recurrent Tumor and Posttreatment Changes in Head and Neck Squamous Cell Carcinoma: Application of High b-Value Diffusion-Weighted Imaging , 2013, American Journal of Neuroradiology.

[8]  C. Glastonbury,et al.  Pleomorphic adenoma of the major salivary glands: Diagnostic utility of FNAB and MRI , 2013, The Laryngoscope.

[9]  Kazunori Kubota,et al.  Can dual-time-point 18F-FDG PET/CT differentiate malignant salivary gland tumors from benign tumors? , 2013, AJR. American journal of roentgenology.

[10]  S. Kim,et al.  The Value of F-18 FDG PET for Planning Treatment and Detecting Recurrence in Malignant Salivary Gland Tumors: Comparison with Conventional Imaging Studies , 2013, Nuclear Medicine and Molecular Imaging.

[11]  T. Murakami,et al.  Conventional MRI findings for predicting submandibular pleomorphic adenoma , 2013, Acta radiologica.

[12]  Jeong Hyun Lee,et al.  Utility of 18F-FDG PET/CT for Detecting Neck Metastasis in Patients with Salivary Gland Carcinomas: Preoperative Planning for Necessity and Extent of Neck Dissection , 2013, Annals of Surgical Oncology.

[13]  M. Sumi,et al.  Head and Neck Tumors: Assessment of Perfusion-Related Parameters and Diffusion Coefficients Based on the Intravoxel Incoherent Motion Model , 2013, American Journal of Neuroradiology.

[14]  A. Saindane,et al.  Pitfalls in the staging of cancer of the major salivary gland neoplasms. , 2013, Neuroimaging clinics of North America.

[15]  G. Moonis,et al.  Patterns of perineural tumor spread in head and neck cancer. , 2012, Magnetic resonance imaging clinics of North America.

[16]  Makoto Obara,et al.  Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. , 2012, Radiology.

[17]  M. Kanematsu,et al.  Mucosa-associated lymphoid tissue lymphoma of the salivary glands: MR imaging findings including diffusion-weighted imaging. , 2012, European journal of radiology.

[18]  A. King,et al.  Diffusion-weighted MR imaging in the head and neck. , 2012, Radiology.

[19]  C. Glastonbury,et al.  Oncocytoma: The Vanishing Parotid Mass , 2011, American Journal of Neuroradiology.

[20]  A. Christe,et al.  MR Imaging of Parotid Tumors: Typical Lesion Characteristics in MR Imaging Improve Discrimination between Benign and Malignant Disease , 2011, American Journal of Neuroradiology.

[21]  H. Thoeny Diffusion-weighted MRI in head and neck radiology: applications in oncology , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[22]  S. Fujii,et al.  Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils , 2010, Acta radiologica.

[23]  D. Heron,et al.  Positron emission tomography‐computed tomography adds to the management of salivary gland malignancies , 2010, The Laryngoscope.

[24]  M. Sumi,et al.  Multiparametric magnetic resonance imaging for the differentiation between benign and malignant salivary gland tumors , 2010, Journal of magnetic resonance imaging : JMRI.

[25]  G. Adam,et al.  Diffusion-Weighted Echo-Planar MR Imaging of Primary Parotid Gland Tumors: Is a Prediction of Different Histologic Subtypes Possible? , 2009, American Journal of Neuroradiology.

[26]  H. Honda,et al.  Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization? , 2008, Radiology.

[27]  M. Kanematsu,et al.  Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland: Radiologic-Pathologic Correlation with MR Imaging Including Diffusion-Weighted Imaging , 2008, American Journal of Neuroradiology.

[28]  T. Vogl,et al.  Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial results. , 2007, European journal of radiology.

[29]  G. Moonis,et al.  Imaging Characteristics of Recurrent Pleomorphic Adenoma of the Parotid Gland , 2007, American Journal of Neuroradiology.

[30]  Jeong Hyun Lee,et al.  Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  D. Yeung,et al.  Salivary gland tumors at in vivo proton MR spectroscopy. , 2005, Radiology.

[32]  Y. Okamoto,et al.  Diagnostic Value of FDG PET and Salivary Gland Scintigraphy for Parotid Tumors , 2005, Clinical nuclear medicine.

[33]  G. Shah MR imaging of salivary glands. , 2004, Magnetic resonance imaging clinics of North America.

[34]  T. Ueda,et al.  Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation. , 2004, AJNR. American journal of neuroradiology.

[35]  H. Matsuzaki,et al.  The value of dynamic contrast-enhanced MRI in diagnosis of malignant lymphoma of the head and neck. , 2003, European journal of radiology.

[36]  Hidetake Yabuuchi,et al.  Index terms: , 2002 .

[37]  L. Ginsberg Imaging pitfalls in the postoperative head and neck. , 2002, Seminars in ultrasound, CT, and MR.

[38]  D. Yousem,et al.  Major salivary gland imaging. , 2000, Radiology.

[39]  G. Chatellier,et al.  Warthin's tumor of parotid gland: Surgery or follow-up? Diagnostic value of a decisional algorithm with functional MRI. , 2016, Diagnostic and interventional imaging.

[40]  Y Dong,et al.  Diagnostic value of CT perfusion imaging for parotid neoplasms. , 2014, Dento maxillo facial radiology.

[41]  M. Sumi,et al.  Head and neck tumours: combined MRI assessment based on IVIM and TIC analyses for the differentiation of tumors of different histological types , 2013, European Radiology.

[42]  M. Brandwein-Gensler,et al.  Anatomy and Pathology of the Salivary Glands , 2011 .